GoHealth Inc.
$ 1.46
4.29%
24 Feb - close price
- Market Cap 40,199,600 USD
- Current Price $ 1.46
- High / Low $ 1.51 / 1.40
- Stock P/E N/A
- Book Value 4.25
- EPS -16.66
- Next Earning Report 2026-02-26
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.02 %
- ROE -1.71 %
- 52 Week High 21.00
- 52 Week Low 1.38
About
GoHealth, Inc. is a health insurance marketplace and a Medicare-focused digital health company in the United States. The company is headquartered in Chicago, Illinois.
Analyst Target Price
$7.70
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-13 | 2025-08-12 | 2025-05-07 | 2025-03-12 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-03-14 | 2023-11-09 | 2023-08-10 | 2023-05-08 | 2023-03-16 |
| Reported EPS | -11.8 | -5.1 | -0.52 | 1.56 | 0.46 | -2.27 | -1.04 | -0.22 | -2.61 | -3.27 | -1.12 | -7 |
| Estimated EPS | -2.36 | -2.13 | -0.3325 | 0.968 | -3.19 | -2.47 | -0.95 | 2.73 | -2.9 | -2.92 | -1.96 | 1.33 |
| Surprise | -9.44 | -2.97 | -0.1875 | 0.592 | 3.65 | 0.2 | -0.09 | -2.95 | 0.29 | -0.35 | 0.84 | -8.33 |
| Surprise Percentage | -400% | -139.4366% | -56.391% | 61.157% | 114.4201% | 8.0972% | -9.4737% | -108.0586% | 10% | -11.9863% | 42.8571% | -626.3158% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-26 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -2.69 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: GOCO
2026-01-21 04:58:51
GoHealth, Inc. (NASDAQ:GOCO) experienced a significant increase in short interest in December, rising by 32.6% to 429,101 shares, representing about 2.3% of shares outstanding. This translates to a short-interest ratio of 4.3 days based on average daily volume. The company's recent quarterly earnings beat EPS estimates but missed revenue expectations, and analysts project a negative EPS for the current fiscal year, with a consensus "Hold" rating and an average price target of $5.
2025-12-13 03:09:13
GoHealth (NASDAQ:GOCO) shares dropped 7.1% on Friday, trading at $3.00, with volume significantly above average. Analyst sentiment remains cautious, holding a consensus "Hold" rating and an average price target of $5.00, following an RBC price target cut and a "sell" rating from Weiss. The company displays weak financial fundamentals, including a negative net margin, a large revenue miss last quarter, and projected negative EPS for the fiscal year, despite beating EPS estimates.
2025-11-23 07:09:38
William Blair downgraded GoHealth (GOCO) to Market Perform from Outperform due to Q3 revenue and Medicare submissions falling below expectations. The firm noted that GoHealth's decision to prioritize profitability over member expansion is prudent given challenging market dynamics. However, the downgrade reflects anticipated persistent market headwinds through 2026, uncertainty regarding GoHealth's ability to generate sustainable positive cash flow, and limited progress in diversifying its business model.
2025-11-22 06:09:31
GoHealth (NASDAQ: GOCO) announced a deliberate reduction in Medicare Advantage volume in Q3 2025 to prioritize member quality, retention, and platform efficiency. The company secured a superpriority term loan and covenant relief to maintain liquidity and strategic flexibility as the Medicare Advantage market undergoes rationalization. Despite a negative market reaction to the news, GoHealth emphasized its focus on high-quality members, retention, and leadership in Special Needs Plans amidst shifting market dynamics.
2025-11-17 04:45:00
GoHealth Inc. has filed an SEC document for the offer and sale of up to 4.8 million shares of its Class A Common Stock. This announcement details the company's intent to sell a significant number of shares, as published on November 17, 2025.
2025-11-17 04:11:24
GoHealth, Inc. released its Q3 2025 financial results, showing a significant decrease in net revenues and a net loss, attributed to a strategic pullback in the Medicare Advantage market. The company focused on retention, quality, and disciplined unit economics, securing a superpriority term loan facility and refreshing its Board to enhance strategic flexibility. Management believes these steps position GoHealth for future growth as market conditions stabilize.
